Treating with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) Accompanying Lower Incidence of Second Primary Cancers

Lung cancer survivors are at risk of developing second primary cancers (SPCs). Although some risk factors for the development of SPCs have been addressed, their impacts have not been clarified. This study, based on Taiwan’s National Health Insurance Research Database (NHIRD), a nationwide database,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Wen-Ru, Shia, Ben-Chang, Huang, Yen-Chun, Ho, Chieh-Wen, Chen, Mingchih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457496/
https://www.ncbi.nlm.nih.gov/pubmed/36079152
http://dx.doi.org/10.3390/jcm11175222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457496/
https://www.ncbi.nlm.nih.gov/pubmed/36079152
http://dx.doi.org/10.3390/jcm11175222

Ejemplares similares